Increasing children’s compliance with oral chemotherapy through partnership
Clinical Previous     Next

Increasing children’s compliance with oral chemotherapy through partnership

Maureen Theurer Charge Nurse/Practice Educator, Respite and Residential Service, Royal Hospital for Sick Children, Edinburgh
Deborah Tomlinson Macmillan Lecturer/Project Leader, Department of Nursing Studies, University of Edinburgh

Oral antimetabolites are the main drugs in the treatment of acute lymphoblastic leukaemia in children. However, children’s compliance with oral chemotherapy has been under question for many years. Nurses need to be aware of the possibility of non-compliance among this population and be involved in developing techniques and strategies in an attempt to minimise this problem. This article discusses how developing partnerships with families can help nurses tackle the issue of non-compliance in children.

Cancer Nursing Practice. 1, 6,19-24. doi: 10.7748/cnp2002.07.1.6.19.c38

Correspondence

Deborah.Tomlinson@ed.ac.uk

Peer review

This article has been subject to double blind peer review

You need a subscription to read the full article